Independent panel to FDA backs Kythera's injection to reduce double chin

March 9, 2015 5:25 PM

17 0

(Reuters) - An injection for double chin reduction developed by Kythera Biopharmaceutical Inc was unanimously backed by an independent panel of experts on Monday, bringing the drug a step closer to approval by the U.S. Food and Drug Administration.

Kythera's stock has nearly tripled since it went public in 2012 as investors bet on what could be the first approved drug in the United States to reduce localized fat deposits.

Read more

To category page